| Group A (n = 162) | Group B (n = 94) | Total (n = 256) | Pvalue | |
---|---|---|---|---|---|
Age* |  | 48.2 ± 13.7 | 47.8 ± 11.2 | 48.1 ± 12.8 | NS |
Female | number (%) | 68 (42.0) | 55 (58.5) | 123 (48.0) | 0.01 |
Follow-up duration* | months | 51.8 ± 40.4 | 88.5 ± 37.8 | 65.3 ± 43.2 | <0.001 |
Initial eGFR*†| ml/min/1.73m2 | 92.4 ± 27.1 | 88.7 ± 32.47 | 91.1 ± 29.2 | NS |
Diabetes mellitus | number (%) | 2 (1.2) | 1 (1.1) | 3 (1.2) | NS |
Hypertension | number (%) | 99 (61.1) | 68 (72.3) | 167 (65.2) | NS |
Urinary stone | number (%) | 24 (14.8) | 16 (17.0) | 40 (15.6) | NS |